首页> 外文学位 >Implantable devices for sensing and drug delivery in ophthalmology and reconstructive surgery.
【24h】

Implantable devices for sensing and drug delivery in ophthalmology and reconstructive surgery.

机译:用于眼科和重建手术中感应和药物输送的可植入设备。

获取原文
获取原文并翻译 | 示例

摘要

Implantable devices have the potential to solve current challenges in both physiological monitoring and drug delivery by introducing in situ measurement and treatment. In this dissertation, two types of implantable devices will be discussed. First, implantable devices for monitoring intraocular pressure (IOP) will be addressed. Second, implantable devices made of both nonbiodegradable and biodegradable materials for bridging a peripheral nerve gap by in situ drug delivery will be discussed.;Elevated IOP serves as a major factor that leads to glaucoma, a permanent vision loss disease, and a real-time monitoring implantable IOP sensor with polydimethylsiloxane membrane that was developed. This IOP sensor can be either implanted in the lens capsular bag after cataract surgery or sandwiched between the sclera and the conjunctiva; the latter being more favorable due to easy signal retrieval. For this approach, batch testing data showed a sensitivity of 0.67 mm/mmHg with the range of the device closely matching that expected for glaucoma patients.;Another medical challenge addressed in this dissertation is that peripheral nerve gaps longer than 10mm require special bridging techniques to repair. Autologous nerve grafts are the gold standard to repair peripheral nerve gaps; however, it possesses donor site deficit. Hence, a drug delivery device consisting of a nerve conduit for guided axon growth is proposed, fabricated and verified in this dissertation. Both nonbiodegradable materials and biodegradable materials were used to make the device that can deliver vascular growth factor, nerve growth factor (NGF), bovine serum albumin and polysaccharide. Furthermore, a bioactivity test verified that the NGF released from the device was still bioactive in promoting axonal outgrowth on chick dorsal root ganglia explants. Two 3-week pilot animal studies in mice and rats also showed that the device is biocompatible with no noticeable inflammatory response. For the release kinetics, the device using diffusion through holes instead of a filter membrane had better consistency in release kinetics. Two mathematical models were also developed to identify the optimal design of the nerve conduit and the model was verified by an in vitro release study. Thus, the model will be used to help determine future nerve conduit designs.
机译:通过引入原位测量和治疗,可植入设备具有解决生理监测和药物输送方面当前挑战的潜力。在本文中,将讨论两种类型的可植入装置。首先,将介绍用于监视眼内压(IOP)的可植入设备。其次,将讨论由不可生物降解材料和可生物降解材料制成的可植入装置,以通过原位药物输送来弥合周围神经间隙。眼压升高是导致青光眼,永久性视力丧失疾病和实时性的主要因素用已开发的带有聚二甲基硅氧烷膜的植入式IOP传感器进行监测。这种IOP传感器可以在白内障手术后植入晶状体囊袋中,也可以夹在巩膜和结膜之间。后者由于易于检索信号而更为有利。对于这种方法,批量测试数据显示灵敏度为0.67 mm / mmHg,并且该设备的范围与青光眼患者的预期值非常匹配。本论文面临的另一项医学挑战是,大于10mm的周围神经间隙需要特殊的桥接技术修理。自体神经移植是修复周围神经间隙的金标准。但是,它具有供体位点缺陷。因此,本文提出,制造和验证了由用于引导轴突生长的神经导管组成的药物输送装置。使用不可生物降解的材料和可生物降解的材料来制造可以输送血管生长因子,神经生长因子(NGF),牛血清白蛋白和多糖的装置。此外,一项生物活性测试证实,从该装置释放的NGF在促进鸡背根神经节外植体的轴突生长方面仍然具有生物活性。在小鼠和大鼠中进行的两项为期3周的试验性动物研究还表明,该装置具有生物相容性,没有明显的炎症反应。对于释放动力学,使用通过孔扩散而不是滤膜的装置在释放动力学方面具有更好的一致性。还开发了两个数学模型来确定神经导管的最佳设计,并通过体外释放研究验证了该模型。因此,该模型将用于帮助确定未来的神经导管设计。

著录项

  • 作者

    Lin, Keng-Min.;

  • 作者单位

    The University of Utah.;

  • 授予单位 The University of Utah.;
  • 学科 Mechanical engineering.;Surgery.;Biomedical engineering.
  • 学位 Ph.D.
  • 年度 2014
  • 页码 179 p.
  • 总页数 179
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号